Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | ATP4A | P20648 | 3/20 | 0.32 |
| ▸ | ATP4B | P51164 | 3/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4981356 | 0.89 | ATP4A (0.35) | L3MBTL1ATP4AATP4BCYP3A4CYP2C9 | |
| SCHEMBL5652760 | 0.87 | ATP4A (0.32) | L3MBTL1ATP4AATP4BCYP3A4CYP2C9 | |
| SCHEMBL4735206 | 0.83 | L3MBTL1 (0.36) | L3MBTL1 | |
| SCHEMBL6487366 | 0.82 | ATP4A (0.35) | ATP4AATP4BCYP3A4CYP2C9 | |
| SCHEMBL5557163 | 0.82 | ATP4A (0.35) | ATP4AATP4BCYP3A4CYP2C9 | |
| SCHEMBL1815255 | 0.80 | RET (0.36) | ATP4AATP4BCYP3A4CYP2C9 | |
| SCHEMBL4731101 | 0.80 | RET (0.36) | ATP4AATP4BCYP3A4CYP2C9 | |
| SCHEMBL6656037 | 0.80 | CYP3A4 (0.36) | L3MBTL1ATP4AATP4BCYP3A4CYP2C9 | |
| SCHEMBL5745833 | 0.80 | CYP3A4 (0.36) | L3MBTL1ATP4AATP4BCYP3A4CYP2C9 | |
| SCHEMBL5744537 | 0.79 | ELANE (0.39) | L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008058990-A1 | 7,7-DISUBSTITUTED PYRANO-[2,3-C]-IMIDAZO-[1,2-A]-PYRIDINE DERIVATIVES AND THEIR USE AS GASTRIC ACID SECRETION INHIBITORS | NYCOMED GMBH (DE) | 2008-05-22 | — | — | WO | disclosed |